>
Switch to:

Allergy Therapeutics Operating Margin %

: -38.77% (As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

Operating Margin % is calculated as Operating Income divided by its Revenue. Allergy Therapeutics's Operating Income for the six months ended in Jun. 2021 was $-16.5 Mil. Allergy Therapeutics's Revenue for the six months ended in Jun. 2021 was $42.5 Mil. Therefore, Allergy Therapeutics's Operating Margin % for the quarter that ended in Jun. 2021 was -38.77%.

The historical rank and industry rank for Allergy Therapeutics's Operating Margin % or its related term are showing as below:

OTCPK:AGYTF' s Operating Margin % Range Over the Past 10 Years
Min: -24.64   Med: 2.18   Max: 10.62
Current: 4.78

-24.64
10.62

OTCPK:AGYTF's Operating Margin % is ranked lower than
52% of the 1043 Companies
in the Drug Manufacturers industry.

( Industry Median: 5.57 vs. OTCPK:AGYTF: 4.78 )

Allergy Therapeutics's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Allergy Therapeutics's Operating Income for the six months ended in Jun. 2021 was $-16.5 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2021 was $4.7 Mil.


Allergy Therapeutics Operating Margin % Historical Data

The historical data trend for Allergy Therapeutics's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Operating Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.96 -9.85 5.96 10.62 4.78

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Operating Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.51 31.69 -27.71 29.20 -38.77

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Allergy Therapeutics Operating Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Operating Margin % falls into.



Allergy Therapeutics Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Allergy Therapeutics's Operating Margin % for the fiscal year that ended in Jun. 2021 is calculated as

Operating Margin %=Operating Income (A: Jun. 2021 ) / Revenue (A: Jun. 2021 )
=5.6535764375877 / 118.2762973352
=4.78 %

Allergy Therapeutics's Operating Margin % for the quarter that ended in Jun. 2021 is calculated as

Operating Margin %=Operating Income (Q: Jun. 2021 ) / Revenue (Q: Jun. 2021 )
=-16.476858345021 / 42.495091164095
=-38.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics  (OTCPK:AGYTF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Allergy Therapeutics Operating Margin % Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)